Endocrinology & Metabolism Clinical Trials

Statistical methods in endocrinology & metabolism trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All endocrinology & metabolism trials

1,009 results

• Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD): Complete Statistical AnalysisIndependent statistical analysis of Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 107NCT00701805
• Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 3Results postedn = 1,299NCT01387737
• Long-Term Study of Nitisinone to Treat Alkaptonuria: Complete Statistical AnalysisIndependent statistical analysis of Long-Term Study of Nitisinone to Treat Alkaptonuria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00107783).Phase 2Results postedn = 40NCT00107783
• Look AHEADIndependent statistical analysis of Look AHEAD (NCT01270763), evaluating intensive lifestyle intervention and diabetes support and education in adults with obesity and type 2 diabetes.n = 4,108NCT01270763
• LOOPAn independent statistical analysis of the LOOP trial of implantable loop recorder monitoring, including trial design, the primary stroke or systemic arterial embolism endpoint, planned time-to-event analysis, and statistical interpretation.Phase NAn = 6,000NCT02036450
• LOSSIndependent statistical analysis of LOSS- Louisiana Obese Subjects Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00115063).Phase 4Results postedn = 390NCT00115063
• LOTUSIndependent statistical analysis of Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the Blood: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 4Results postedn = 53NCT02839902
• LYNXIndependent statistical analysis of A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir…Phase NAResults postedn = 346NCT01159743
• M-F0434Independent statistical analysis of Neuropathic Pain Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263132).Phase 3Results postedn = 104NCT01263132
• MAGE-A4ᶜ¹º³²T for Multi-Tumor: Complete Statistical AnalysisIndependent statistical analysis of MAGE-A4ᶜ¹º³²T for Multi-Tumor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03132922).Phase 1Results postedn = 71NCT03132922
• Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE): Complete Statistical AnalysisIndependent statistical analysis of Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01525875).Phase 2Results postedn = 44NCT01525875
• MAHIIndependent statistical analysis of Feasibility Study to Evaluate Safety and Device Performance of the Hospital Glucose Management System (HGMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 19NCT01763567
• MALMSIndependent statistical analysis of Metformin to Augment Low Milk Supply (MALMS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02179788).Phase 1/2Results postedn = 15NCT02179788
• Manipulating the Gut Microbiome Study: Complete Statistical AnalysisIndependent statistical analysis of Manipulating the Gut Microbiome Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03181828).Phase 1/2Results postedn = 4NCT03181828
• MankaiIndependent statistical analysis of Protein Bioavailability of Wolffia Globosa (Mankai); Acute Test Meal Effects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03020225).Phase NAResults postedn = 36NCT03020225
• MAPP-IIIndependent statistical analysis of Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: Proof-of Concept Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 8NCT03473886
• MARSIndependent statistical analysis of Microvascular Flow Assessment Repeatability Study: The MARS Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01242020).Phase NAResults postedn = 6NCT01242020
• Massive Iron Deposit Assessment: Complete Statistical AnalysisIndependent statistical analysis of Massive Iron Deposit Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01572922).Phase NAResults postedn = 142NCT01572922
• MATCh-GDMIndependent statistical analysis of Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029702).Phase 4Results postedn = 54NCT03029702
• Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 147NCT03244722
• MDB003Independent statistical analysis of Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase NAResults postedn = 38NCT01418703
• MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 27NCT00112580
• Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment: Complete Statistical AnalysisIndependent statistical analysis of Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 1,103NCT02637622
• Mechanisms of Hypoglycemia Associated Autonomic Failure: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Hypoglycemia Associated Autonomic Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678145).Phase 2Results postedn = 39NCT00678145
• Mechanisms of Lipodystrophy in HIV-Infected Pateints: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Lipodystrophy in HIV-Infected Pateints: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00457665).Phase 4Results postedn = 56NCT00457665
• MedstarBC2Independent statistical analysis of MedStar Diabetes Pathway Chart Reviews: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03442595).Phase NAResults postedn = 826NCT03442595
• Medtronic MiniMed Implantable Insulin Pump: Complete Statistical AnalysisIndependent statistical analysis of Medtronic MiniMed Implantable Insulin Pump: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298740).Phase NAResults postedn = 12NCT00298740
• MelaOstrongIndependent statistical analysis of Melatonin and Osteogenic Loading on Osteopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04233112).Phase EARLY_1Results postedn = 27NCT04233112
• Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: Complete Statistical AnalysisIndependent statistical analysis of Men Together Making a Difference: Reducing HIV/STD Risk Behavior Among South African Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase NAResults postedn = 1,181NCT01490359
• MENDEL-2Independent statistical analysis of Monoclonal Antibody Against PCSK9 to Reduce Elevated LDL-C in Subjects Currently Not Receiving Drug Therapy for Easing Lipid Levels-2: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 615NCT01763827
• Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): Complete Statistical AnalysisIndependent statistical analysis of Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00805935).Phase 4Results postedn = 110NCT00805935
• MeT1Independent statistical analysis of Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 4Results postedn = 23NCT01813929
• Metabolic Effects of Sleep Extension in People With Obesity: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Effects of Sleep Extension in People With Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03594994).Phase NAResults postedn = 31NCT03594994
• Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Phenotyping During Stress Hyperglycemia in Cardiac Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03743025).Phase 4Results postedn = 28NCT03743025
• Metabolic Syndrome and Fall Risk: Complete Statistical AnalysisIndependent statistical analysis of Metabolic Syndrome and Fall Risk: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02633891).Phase NAResults postedn = 12NCT02633891
• Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): Complete Statistical AnalysisIndependent statistical analysis of Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1Results postedn = 13NCT00418561
• Metformin in Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Metformin in Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02252081).Phase 2Results postedn = 125NCT02252081
• Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Metformin Versus Insulin in Pregnant Women With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678080).Phase NAResults postedn = 25NCT00678080
• Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer: Complete Statistical AnalysisIndependent statistical analysis of Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase NAResults postedn = 1NCT00726830
• MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT): Complete Statistical AnalysisIndependent statistical analysis of MGTA-456 in Patients With Inherited Metabolic Disorders Undergoing Hematopoietic Stem Cell Transplantation (HSCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 8NCT03406962
• MH MOVE!Independent statistical analysis of Improving Obesity Self-Care Among Mentally Ill Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02642536).Phase NAResults postedn = 44NCT02642536
• MicroVasc-DIVAIndependent statistical analysis of Microvascular and Antiinflammatory Effects of Rivaroxaban Compared to Aspirin in Type-2 Diabetic Patients With Subclinical Inflammation and High Cardiovascular Risk: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 179NCT02164578
• MiDME2Independent statistical analysis of Dextromethorphan for Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01441102).Phase 1/2Results postedn = 7NCT01441102
• MINDDIndependent statistical analysis of Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 4Results postedn = 5NCT03380091
• Minimally Invasive Surgery (MIS) Database for the Purpose of Research: Complete Statistical AnalysisIndependent statistical analysis of Minimally Invasive Surgery (MIS) Database for the Purpose of Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00535990).Phase NAResults postedn = 250NCT00535990
• Mitigation of Major Hip Injury Due to Fall With a Smart Belt: Complete Statistical AnalysisIndependent statistical analysis of Mitigation of Major Hip Injury Due to Fall With a Smart Belt: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 471NCT05245097
• MitoCKDIndependent statistical analysis of Mitochondria and Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03177798).Phase 2Results postedn = 11NCT03177798
• MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 3Results postedn = 134NCT00372060
• MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00482729).Phase 3Results postedn = 1,246NCT00482729
• MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 31NCT00853307

← All therapeutic areas